AA
BMY icon

AlphaQ Advisors’s Bristol-Myers Squibb BMY Stock Holding History

AlphaQ Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,473
Closed -$281K – 160
2023
Q4 		$281K Sell
5,473
-384
-7% -$20.2K 0.19% 122
2023
Q3 		$340K Sell
5,857
-710
-11% -$43.5K 0.29% 99
2023
Q2 		$420K Buy
6,567
+1,049
+19% +$70.3K 0.31% 88
2023
Q1 		$382K Sell
5,518
-1,124
-17% -$79.3K 0.33% 91
2022
Q4 		$478K Buy
+6,642
New +$501K 0.41% 65

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AlphaQ Advisors's BMY Position: Q1 2024 in Review

AlphaQ Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 5,473 shares — an estimated $281K sold.

AlphaQ Advisors first reported a position in BMY in Q4 2022 and held it in 5 quarters. The position peaked at $478K in Q4 2022. 2,339 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • AlphaQ Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
  • AlphaQ Advisors sold 5,473 Bristol-Myers Squibb shares in Q1 2024, an estimated $281K.
  • AlphaQ Advisors first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 5 quarters.
  • AlphaQ Advisors's Bristol-Myers Squibb position peaked at $478K in Q4 2022.
  • 2,339 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on AlphaQ Advisors's 13F filing for Q1 2024, filed 2 May 2024.